Pharmaceutical and/or Biotechnology

At a time when pharmaceutical and biotechnology businesses around the world are grappling with declining R&D productivity, Singapore’s integrated research ecosystem enables companies to access multidisciplinary capabilities in a single location, which improves R&D decision-making and accelerates drug discovery and development. Focused on developing a vibrant biomedical sciences research ecosystem, Singapore has built up a strong scientific foundation with seven research institutes and five research consortia in key fields that include clinical sciences, genomics, bioengineering, molecular/cell biology, medical biology, bio-imaging and immunology. More than 50 companies are carrying out biomedical sciences R&D that includes drug discovery, translational and clinical research, frequently collaborating with these research institutes.

Looking ahead, Singapore has committed S$16.1 billion in continued support of research, innovation and enterprise activities between 2011 and 2015. Out of the S$16.1 billion, S$3.7 billion is dedicated to enhancing existing biomedical R&D infrastructure, integrating multi-disciplinary research and translating basic science into tangible outcomes.

 

Did you know?

• Singapore is reputed for its clinical research and clinical trials management activities in Asia. As the secretariat for the APEC Coordinating Centre for Good Clinical Practice (GCP), Singapore plays a strategic role in developing GCP in Asia, steering initiatives such as the training of clinical research personnel and developing a conducive environment for multi-site clinical trials in the region.

Novartis Singapore Pharmaceutical Manufacturing

http://www.novartis.com

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2013, the Group achieved net sales of USD 57.9 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 133,000 full-time-equivalent associates and sell products in more than 150 countries around the world.

Singapore is a strategic hub for Novartis. Novartis currently employs approximately 1,500 full-time equivalent associates in Singapore.

Novartis associates are provided with lifelong learning and development opportunities so as to advance personally and professionally together with the flexibility to explore and implement ideas in a lean organization, with empowered and highly skilled associates and cross-functional insights.

Potential Career Path:

Scholars will be exposed to a Process Oriented Organization culture that focuses on accountability, empowerment, being self-directed and practicing informal leadership skills. Other opportunities would be through innovative and collaborative projects that build depth of experience and networking opportunities to enhance their outlook on different career paths available. Possible career paths includes:-

• Process Engineers
• Process Experts
• Analytical Chemist
• Product Stewards
• Quality Compliance Officer

Preferred Courses of Study:

• Project and Facilities Management
• Engineering (Chemical / Electrical / Electronic / Industrial and Systems / Materials Science and Engineering / Mechanical Design and Manufacturing / Mechanical / Mechatronics)
• Science (Biological Sciences / Chemistry and Biological Chemistry / Life Sciences / Pharmacy / Statistics)